CASTORIA, Gabriella
 Distribuzione geografica
Continente #
EU - Europa 9.856
NA - Nord America 5.800
AS - Asia 4.574
SA - Sud America 591
Continente sconosciuto - Info sul continente non disponibili 432
AF - Africa 52
OC - Oceania 11
Totale 21.316
Nazione #
RU - Federazione Russa 6.023
US - Stati Uniti d'America 5.700
SG - Singapore 1.449
IE - Irlanda 1.022
CN - Cina 993
IT - Italia 924
HK - Hong Kong 585
BR - Brasile 497
UA - Ucraina 474
VN - Vietnam 465
GB - Regno Unito 449
IN - India 323
DE - Germania 314
TR - Turchia 291
KR - Corea 217
FI - Finlandia 184
SE - Svezia 132
FR - Francia 102
JP - Giappone 88
GR - Grecia 78
CA - Canada 49
BE - Belgio 42
AR - Argentina 32
BD - Bangladesh 27
MX - Messico 26
NL - Olanda 26
PK - Pakistan 22
AT - Austria 16
ID - Indonesia 16
IQ - Iraq 16
JO - Giordania 15
CO - Colombia 14
EC - Ecuador 13
ES - Italia 12
PL - Polonia 12
VE - Venezuela 11
MA - Marocco 9
PY - Paraguay 9
UZ - Uzbekistan 9
ZA - Sudafrica 9
IR - Iran 7
KE - Kenya 7
PH - Filippine 7
TH - Thailandia 7
AU - Australia 6
BG - Bulgaria 6
DZ - Algeria 6
EG - Egitto 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CL - Cile 5
HU - Ungheria 5
NO - Norvegia 5
PE - Perù 5
SV - El Salvador 5
DO - Repubblica Dominicana 4
HR - Croazia 4
NZ - Nuova Zelanda 4
PA - Panama 4
TN - Tunisia 4
UY - Uruguay 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
IL - Israele 3
LT - Lituania 3
NP - Nepal 3
PT - Portogallo 3
RO - Romania 3
SN - Senegal 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
HN - Honduras 2
JM - Giamaica 2
KZ - Kazakistan 2
RS - Serbia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BJ - Benin 1
BM - Bermuda 1
BN - Brunei Darussalam 1
CH - Svizzera 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
Totale 20.880
Città #
Moscow 2.186
Dublin 1.015
San Jose 762
Jacksonville 723
Singapore 722
Chandler 714
Santa Clara 643
Hong Kong 572
Bengaluru 287
Ashburn 263
Ann Arbor 202
Seoul 201
Beijing 178
Hefei 163
Ho Chi Minh City 156
Caserta 147
Princeton 141
Naples 129
Hanoi 124
Boardman 118
Council Bluffs 108
Istanbul 104
Medford 100
Roxbury 92
Los Angeles 85
Bremen 82
Woodbridge 75
Dallas 74
Wilmington 73
San Mateo 54
The Dalles 47
São Paulo 44
Cambridge 42
Nanjing 42
Brussels 40
Helsinki 38
Rome 38
New York 37
Da Nang 36
Aversa 33
Napoli 33
Houston 32
Munich 30
Jinan 29
Des Moines 25
Mountain View 23
Turku 23
Rio de Janeiro 22
Orem 21
Pozzuoli 20
Frankfurt am Main 18
London 17
Norwalk 17
Shanghai 17
Kunming 16
Milan 16
Shenyang 16
Tokyo 15
Guangzhou 14
Seattle 14
Amman 13
Belo Horizonte 13
Chennai 13
Haiphong 13
Amsterdam 12
Nanchang 12
Afragola 11
Biên Hòa 11
Düsseldorf 11
Hanover 11
Hải Dương 11
Phoenix 11
Toronto 11
Vienna 11
Atlanta 10
Brooklyn 10
Catanzaro 10
Chicago 10
Memphis 10
Salerno 10
Somma Vesuviana 9
Tashkent 9
Tricesimo 9
Zhengzhou 9
Boston 8
Cabo Frio 8
Falkenstein 8
Redwood City 8
Tianjin 8
Warsaw 8
Auburn Hills 7
Charlotte 7
Dearborn 7
Dhaka 7
Ercolano 7
Giugliano in Campania 7
Mumbai 7
Nairobi 7
Nuremberg 7
Queens 7
Totale 11.486
Nome #
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. 303
'Role of PI3-K signaling in steroid action’ 215
CROSS-TALK BETWEEN ANDROGEN RECEPTOR AND NERVE GROWTH FACTOR RECEPTOR IN PROSTATE CANCER CELLS: IMPLICATIONS FOR A NEW THERAPEUTIC APPROACH. 200
A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers 198
Androgen regulation of motility in fibroblasts 197
Effect of new androgen receptor antagonists (SARMs) in the treatment of human prostate cancer. 195
Polyproline and Tat transduction peptides in the study of the rapid actions of steroid receptors 189
Calmodulin-stimulated estradiol receptor-tyrosine kinase I 187
Breast cancer stem cells: The role of sex steroid receptors 187
Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells 186
Androgen receptor targeted conjugate for bimodal photodynamic therapy of prostate cancer in vitro. 184
Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. 184
Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth 181
CROSS TALK BETWEEN ANDROGEN RECEPTOR/ FILAMIN A AND TrkA REGULATES NEURITE OUTGROWTH IN PC12 CELLS 181
Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. 180
Androgen-induced cell migration: role of androgen receptor/filamin A association. 180
Activation-inactivation of hormone binding sites of the oestradiol-17 beta receptor is a multiregulated process 178
Analysis of the Androgen Receptor/Filamin A Complex in Stromal Cells 178
Patologia Generale 177
Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer 175
Analysis of androgen receptor rapid actions in cellular signaling pathways: receptor/src association 173
Integrating signals between cAMP and MAPK pathways in breast cancer 172
Crosstalk between EGFR and extranuclear steroid receptors. 172
Protein tyrosine phosphorylation and estradiol action 170
Sex steroid hormones act as growth factors 170
Targeting rapid action of sex-steroid receptors in breast and prostate cancers. 170
High-throughput screening identifies kinase inhibitors that increase dual AAV vectors transduction in vitro and in mouse retina. 170
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. 168
Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor a alpha tyrosine-phosphorylated peptide 167
Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells through AR/Src/PI3-K Complex Assembly. 167
Activation of the Src/Ras/Erks pathway is required for steroid-induced S-phase entry of human mammary carcinoma-derived cells 166
Discovering New Targets in Triple-Negative Breast Cancer (TNBC): The Androgen Receptor and the Estrogen Receptor β. 165
Agri-Food By-Products in Cancer: New Targets and Strategies. 165
Activation of Src/Ras/Erks sgnalling pathway is required for steroid-induced DNA synthesis 165
Advances in Rapid Sex-Steroid Action New Challenges and New Chances in Breast and Prostate Cancers 164
cAMP pathway in differentiating myoblast 163
'Steroid-activated PI3-K pathway in target cells'. 163
Action of vanadate on estrogen dependent MCF-7 cells. 163
Steroid induced androgen receptor-oestardiol receptor ß- Src complex triggers prostate cancer cell proliferation 161
Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications. 161
Activation of c-src/p21ras/erks pathway by steroids and its role in human mammary cancer cell lines. 160
THE DUAL ROLE OF ANDROGEN RECEPTOR IN MESENCHYMAL CELLS. 159
Rapid signalling pathway activation by androgens in epithelial and stromal cells 158
A New Avenue toward Androgen Receptor Pan-antagonists: C2 Sterically Hindered Substitution of Hydroxy-propanamides. 158
Estradiol activation of human colon carcinoma-derived Caco-2 cell growth 156
Activation of Src/Ras/Erks sgnalling pathway is required for steroid-induced DNA synthesis 156
EXTRA-NUCLEAR PARTNERS OF ANDROGEN RECEPTOR: AT THE CROSSROADS OF PROLIFERATION, MIGRATION AND NEURITOGENESIS. 154
Differentiation of H9c2 cardiomyoblasts: The role of adenylate cyclase system. 153
Src is an initial target of sex steroid hormone action. 151
Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer. 151
Communication between cells: exosomes as a delivery system in prostate cancer. 151
ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities 151
Androgens and NGF Mediate the Neurite-Outgrowth through Inactivation of RhoA. 150
Role of the Androgen Receptor in Gender-Related Cancers. 150
Cell proliferation regulated by estradiol receptor: therapeutic implications. 150
The Androgen Regulation of Matrix Metalloproteases in Prostate Cancer and Its Related Tumor Microenvironment. 149
In vitro phosphorylation and hormone binding activation of the synthetic wild type human estradiol receptor 149
Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer 149
Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells. 148
Binary switch between adjacent marks in histone H3 directs productive transcription in estrogen-induced breast cancer cells upon cyclical creation of ROS. 148
RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer. 146
A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells 145
The Role of the Androgen Receptor in Skeletal Muscle and Its Utility as a Target for Restoring Muscle Functions. 145
Androgens as the “old age stick” in skeletal muscle (Correction: Androgens as the “old age stick” in skeletal muscle) 142
Estrogens Modulate Somatostatin Receptors Expression and Synergizes With the Somatostatin Analog Pasireotide in Prostate Cells 141
Filamin A cooperates with the androgen receptor in preventing skeletal muscle senescence 140
Cross talk between epidermal growth factor (EGF) receptor and extra nuclear steroid receptors in cell lines. 140
Steroid signaling activation and intracellular localization of sex steroid receptors 139
Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. 139
Control of cell proliferation by estradiol and protein tyrosine phosphorilation. 139
Biochemical and Pathophysiological Premises to Positron Emission Tomography With Choline Radiotracers. 137
Alterazioni del Sistema Endocrino- Sezione E " Fisiopatologia Molecolare degli Organi e dei sistemi"- 136
Prostate cancer stem cells: the role of androgen and estrogen receptors. 136
Non-Steroidal Androgen Receptor Ligands: Versatile Syntheses and Biological Data. 135
Phosphorylation on tyrosine of oestradiol-17 beta receptor in uterus and interaction of oestradiol-17 beta and glucocorticoid receptors with antiphosphotyrosine antibodies 135
Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models. 135
Phosphorylation of H3 serine 10 by IKKα governs cyclical production of ROS in estrogen-induced transcription and ensures DNA wholeness. 134
Le basi cellulari e molecolari delle malattie per le lauree triennali e magistrali 134
Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells. 133
Targeting the Nerve Growth Factor Signaling Impairs the Proliferative and Migratory Phenotype of Triple-Negative Breast Cancer Cells. 132
Filamin A in triple negative breast cancer. 130
THE ROLE OF THE ANDROGEN RECEPTOR IN SKELETAL MUSCLE SENESCENCE. 129
Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance 129
New insights and emerging therapeutic approaches in prostate cancer. 129
The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells 128
The role of androgen receptor/filamin A association in androgen-induced cell migration 128
Searching for a putative mechanism of tumor-promoting function of RIZ2 in cancer models 127
Targeting androgen receptor/Src complex impairs the aggressive phenotype of human fibrosarcoma cells. 126
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models. 126
The role of androgen receptor in stromal cells. 125
ICI 164,384 e ICI 182,780 prevengono l’atività proliferativa del recettore dell’estradiolo mediata dalla fosforilazione delle proteine. 125
Novel aspects of signalling activation by steroid hormones in target cells. 125
Non-genomic action of steroid hormones: More questions than answers 124
Acetylation/methylation at lysine 9 in histone H3 as a mark of nucleosome asymmetry in human somatic breast cells 124
Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells. 122
Dephosphorylation of oestradiol nuclear receptor in vitro. A hypothesis on the mechanism of action of non-steroidal anti-oestrogens 121
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol receptor complex in MCF-7 cells 121
Inhibitors targeting the Src/Ras/Erks pathway prevent cancer cell S-phase entry induced by steroids. 121
Nerve Growth Factor Induces Proliferation and Aggressiveness In Prostate Cancer Cells. 120
Phosphorylation of uterus estradiol receptor on tyrosine 118
Totale 15.502
Categoria #
all - tutte 69.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022959 0 19 18 29 338 32 28 28 28 86 78 275
2022/20232.338 155 71 28 243 242 228 11 174 1.045 24 61 56
2023/2024979 105 39 33 86 282 48 40 55 16 35 96 144
2024/20252.558 14 21 33 171 393 355 374 192 330 278 210 187
2025/202610.801 505 761 466 391 877 5.639 620 545 433 279 152 133
2026/2027266 53 213 0 0 0 0 0 0 0 0 0 0
Totale 21.316